Novel approaches are needed to address the general wellbeing of patients with cancer. Studies presented at #ESMO25 add to growing evidence supporting the use of #DigitalTools.
Find out more in the #ESMODailyReporter 👉 https://ow.ly/uSpY50XjC7Q

#CancerCare #DigitalHealth

@paoli-calmettes.bsky.social célèbre un siècle d’activités de soins, de recherches et de formations par une série de conférences thématiques. Le 5 Novembre venez écouter comment les innovations diagnostiques et thérapeutiques sont développées et mises en œuvre dans le domaine de l’onco-hématologie

@paoli-calmettes.bsky.social celebrates a century of intermingled care, research and éducation for the benefit of patients in Southeastern France. On Nov 5th, listen to a string of présentations depicting progress in Hematology and how diagnostic and therapeutic innovations are being implemented

Honoured to speak today along with #ACTO2025 the 16th #ACTO Annual Meeting in Singapore. Describing the #GoCART Coalition vision, mission & activities to foster the development and access to #CART Cells therapies in Europe @theebmt.bsky.social

New approach enables body to engineer its own cells to fight cancer or autoimmunity | Science | AAAS www.science.org/content/arti...

Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma | New England Journal of Medicine www.nejm.org/doi/full/10....

Through deep financial cuts and restrictions on #research, the first 100 days of the Trump administration led to the upheaval of the U.S. #biomedical infrastructure. Below, #hematologists share how these policies are affecting the future of #patient care: ow.ly/4lGK50VY4V6
#HemeSky #MedSky

Research may be increasingly incremental—but studies making lasting paradigm shifts are on the rise | Science | AAAS www.science.org/content/arti...

European cancer mortality predictions for the year 2025 with focus on breast cancer - Annals of Oncology www.annalsofoncology.org/article/S092...
Cannot resist sharing good news!

Distinct adipose progenitor cells emerging with age drive active adipogenesis | Science www.science.org/doi/10.1126/...

🕵️‍♀️ In this cancer Clue game:
🧬 Victim: CSCs
🔪 Weapon: Nifuroxazide
🎯 Mode: DNA crosslinks + STAT3 block
🧬 Scene: PARPi-resistant breast cancer

From the Charafe/Ginestier team @CRCM
🔗 pubmed.ncbi.nlm.nih.gov/40038300/

✍️ by @celiarouault.bsky.social
🔗 communities.springernature.com/posts/unveil...

I am thrilled to share my first paper published in @naturecomms.bsky.social, Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARPi in breast cancer @Christophe Ginestier @emmanuellecharafe.bsky.social I thanks all the collaborators and supporters
rdcu.be/ecaao

Félicitations au Pr. @ericvivier.bsky.social, du Centre d’Immunologie de Marseille-Luminy, lauréat du Prix ARC Léopold Griffuel ! Une belle reconnaissance pour ses avancées majeures en immunothérapie 🔬👏

#Recherche #Immunologie #AMU #ExcellenceScientifique

Longest human transplant of pig kidney fails | Science | AAAS www.science.org/content/arti...

🚀 Lancement de l’Appel à Manifestation d'Intérêt (AMI) Immunologie d’Amidex !

Ce programme met en relation les projets académiques du site d'Aix-Marseille avec les plateformes de pointe BScreen et CellScale, intégrées au Marseille Immunology Biocluster.

👉+d'infos : www.univ-amu.fr/fr/public/ac...

Editor-in-chief @chadoc13.bsky.social discusses the 2nd edition of the EU CAR-T Handbook, highlighting key updates, emerging innovations & how it supports transplant professionals in delivering advanced cellular treatments. #EBMT25 youtu.be/MwYwDJfzKus